Next Article in Journal
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Next Article in Special Issue
Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance
Previous Article in Journal
Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
Previous Article in Special Issue
Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5′-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes
 
 
Article

Article Versions Notes

Pharmaceutics 2020, 12(3), 268; https://doi.org/10.3390/pharmaceutics12030268
Action Date Notes Link
article xml file uploaded 15 March 2020 11:24 CET Original file -
article pdf uploaded. 15 March 2020 11:24 CET Version of Record https://www.mdpi.com/1999-4923/12/3/268/pdf-vor
article xml file uploaded 18 March 2020 10:02 CET Update -
article xml uploaded. 18 March 2020 10:02 CET Update https://www.mdpi.com/1999-4923/12/3/268/xml
article pdf uploaded. 18 March 2020 10:02 CET Updated version of record https://www.mdpi.com/1999-4923/12/3/268/pdf
article html file updated 18 March 2020 10:04 CET Original file -
article html file updated 1 April 2020 18:01 CEST Update -
article html file updated 20 July 2022 23:00 CEST Update https://www.mdpi.com/1999-4923/12/3/268/html
Back to TopTop